The heatmap shows the main differential metabolites between the control and Pim-2 kinase inhibitor-treated MM cells (Figure 2A,B), indicating that the inhibition of Pim-2 leads to a significant reduction in metabolites. Here, PIM2 is linked to Miyoshi myopathy.